Plasma-Derived Medicines

Over the past three years, a total of 2.5 million units of blood plasma have been sent to Germany and Switzerland for production of plasma-derived medicines, said the director general of Iran Blood Transfusion Organization.”This amount was the surplus plasma after the domestic need was met,” said Ali Akbar Pourfathollah, at the 6th meeting of managers of blood transfusion centers in the country in Semnan Province, IRNA reported. The Tehran Blood Transfusion Center received the biennial certification for optimal plasma production from CSL-Plasma Inc. in Germany in February. The current level of plasma production in the country is 400,000 liters.